Article
Congenital adrenal hyperplasia due to 11-hydroxylase deficiency--insights from two novel CYP11B1 mutations (p.M92X, p.R453Q).
Hormone research - 1 Jan 2009
Krone Nils, Grötzinger Joachim, Holterhus Paul-Martin, Sippell Wolfgang G, Schwarz Hans-Peter, Riepe Felix G
Abstract excerpt
BACKGROUND: Steroid 11-hydroxylase (CYP11B1) deficiency (11OHD) is the second most common form of congenital adrenal hyperplasia (CAH). Herein, we describe two novel CYP11B1 mutations (g659_660dupTG, p.M92X; g.4817G>A, p.R453Q) found in a patient diagnosed with classic 11OHD, after presenting with borderline elevated 17-hydroxyprogesterone concentrations in CAH newborn screening. METHODS: A novel CYP11B1 variant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
